Chicago Equity Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Chicago Equity Partners’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-14,185	Closed	-$758K	–	742
2016 Q1	$758K	Buy	14,185 +130	+0.9%	+$9.6K	0.02%	399
2015 Q4	$1.59M	Sell	14,055 -1,335	-9%	-$147K	0.04%	292
2015 Q3	$1.81M	Buy	15,390 +10,425	+210%	+$1.36M	0.05%	271
2015 Q2	$384K	Buy	4,965 +30	+0.6%	+$1.97K	0.01%	373
2015 Q1	$285K	Buy	+4,935	New	+$210K	0.01%	394

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Chicago Equity Partners's ANAC Position: Q2 2016 in Review

Chicago Equity Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 14,185 shares — an estimated $758K sold.

Chicago Equity Partners first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $1.81M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Chicago Equity Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Chicago Equity Partners sold 14,185 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $758K.
Chicago Equity Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
Chicago Equity Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $1.81M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Chicago Equity Partners's 13F filing for Q2 2016, filed 29 Jul 2016.